Multimodal Imaging Analysis of Retinal and Microvascular Changes in Alport Syndrome
By
Irem Kirci Dogan
Caner Incekas
Imren Akkoyun
Sezin Akca Bayar
Gursel Yilmaz
January 19, 2026
Clinical Scorecard: Multimodal Imaging Analysis of Retinal and Microvascular Changes in Alport Syndrome
At a Glance
Category Detail
Condition Alport Syndrome Key Mechanisms Pathogenic variants in COL4A3, COL4A4, or COL4A5 genes affecting type IV collagen structure. Target Population Patients with genetically or clinically confirmed Alport syndrome. Care Setting Tertiary referral center.
Key Highlights
Prevalence estimated at 1 in 2,320 for X-linked and 1 in 106 for autosomal dominant forms. Ocular manifestations include anterior lenticonus and dot-and-fleck retinal changes. Microvascular alterations observed via OCT-A, including reduced FAZ area and vascular density. Study involved 34 patients with AS and 68 matched controls. Comprehensive evaluation using spectral-domain OCT and swept-source OCT-A. Guideline-Based Recommendations
Diagnosis
Genetic confirmation via pathogenic variants in COL4A3, COL4A4, or COL4A5. Clinical diagnosis based on systemic and ocular features. Management
Regular ophthalmologic examinations including BCVA and fundus examination. Monitoring & Follow-up
Utilization of OCT and OCT-A for assessing retinal structure and microvascular changes. Risks
Exclusion of patients with other retinal diseases or significant media opacity. Patient & Prescribing Data
Patients with genetically or clinically confirmed Alport syndrome.
Focus on monitoring ocular manifestations and structural changes.
Clinical Best Practices
Conduct comprehensive ophthalmologic examinations. Utilize OCT for detailed retinal layer analysis. Ensure accurate genetic testing for diagnosis. Related Resources & Content
